Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Solara Active Pharma Sciences Rights Issue 2024 and Viji Finance Rights Issue 2024.
Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Solara Active Pharma Sciences Rights Issue 2024 and Viji Finance Rights Issue 2024. Solara Active Pharma Sciences Rights Issue 2024 is listed on BSE, NSE while Viji Finance Rights Issue 2024 is listed on BSE, NSE.
| Solara Active Pharma Sciences Ltd | Viji Finance Ltd | |
|---|---|---|
| Logo |  |
 |
| Listing At | BSE, NSE | BSE, NSE |
| Terms of Payment | Issue Price of Rs.375/- per share is payable as Rs.131.25 per share on Application. The remaining amount will be called within 24 months from the date of allotment in the Issue or within such extended period as may be determined by the Board or Rights Issue Committee of the Company at its sole discretion from time to time. |
All money payable at the time of Application. |
| Entitlement | 1 Rights Equity Share(s) for every 3 fully paid-up Equity Shares held on Record Date | 8 Rights Equity Share(s) for every 11 fully paid-up Equity Shares held on Record Date |
| Application Form | Application Form  |
Application Form |
| Letter of Offer | Letter of Offer |
Letter of Offer |
| Registrar | Cameo Corporate Services Limited | Cameo Corporate Services Limited |
| Lead Managers | Choice Capital Advisors Pvt Ltd |
The issue size of Solara Active Pharma Sciences Rights Issue 2024 rights issue is ₹449.95 Crores, whereas Viji Finance Rights Issue 2024 rights issue size is ₹9.00 Crores.
| Solara Active Pharma Sciences Ltd | Viji Finance Ltd | |
|---|---|---|
| Issue Size | 1,19,98,755 shares | 6,00,00,000 shares |
| Issue Size (Amount) | ₹449.95 Crores | ₹9.00 Crores |
| Issue Price | ₹375 per share | ₹1.5 per share |
| Face Value | ₹10 per share | ₹1 per share |
Find all the important dates related to the rights issue. The record date of Solara Active Pharma Sciences Rights Issue 2024 is May 15, 2024 while record date of Viji Finance Rights Issue 2024 is May 15, 2024.
| Solara Active Pharma Sciences Ltd | Viji Finance Ltd | |
|---|---|---|
| Record Date | May 15, 2024 | May 15, 2024 |
| Credit of Rights Entitlements | May 27, 2024 | May 24, 2024 |
| Bid/Offer Opens On | May 28, 2024 | May 28, 2024 |
| Renunciation of Rights Entitlements | Jun 05, 2024 | Jun 04, 2024 |
| Bid/Offer Closes On | Jun 11, 2024 | Jun 26, 2024 |
| Deemed Date of Allotment | Jun 19, 2024 | Jun 14, 2024 |
| Credit Date | Jun 19, 2024 | Jun 19, 2024 |
| Listing Date | Jun 20, 2024 | Jun 24, 2024 |
Comparison of Solara Active Pharma Sciences Rights Issue 2024 and Viji Finance Rights Issue 2024 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.
| Solara Active Pharma Sciences Ltd | Viji Finance Ltd | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial | Solara Active Pharma Sciences Ltd Financial Information (Restated Consolidated)Solara Active Pharma Sciences Ltd's revenue increased by 13.82% and profit after tax (PAT) rose by 61.85% between the financial year ending with March 31, 2023 and March 31, 2022.
|
Viji Finance Ltd Financial Information (Restated Consolidated)Viji Finance Ltd's revenue increased by 64.41% and profit after tax (PAT) dropped by -1.66% between the financial year ending with March 31, 2023 and March 31, 2022.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
